share_log

HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $59 Price Target

Benzinga ·  May 15 11:26

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $59 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment